I’ve been quite bullish on Exact Sciences (NASDAQ:EXAS) stock for a while now. In January, I pointed out some reasons the molecular-diagnostics stock should go much higher. Since I wrote that article, Exact Sciences’ share price indeed has gone much higher -- almost doubling.
After this huge run-up, can Exact Sciences stock still go a lot higher?
